Northwest Biotherapeutics Inc., of Bethesda, Md., was issued U.S. Patent No...StemCells Inc., of Newark, Calif., acquired U.S. Patent Nos...Zalicus Inc., of Cambridge, Mass., was issued U.S. Patent No

Addex Therapeutics SA, of Geneva, was issued U.S. Patent No...Anergis, of Epalinges, Switzerland, was issued U.S. Patent No...NeoStem Inc., of New York, was issued U.S. Patent No

Immunomedics Inc., of Morris Plains, N.J., was issued U.S. Patent No...MonoSol Rx LLC, of Warren, N.J., has acquired U.S. Patent No...RedHill Biopharma Ltd., of Tel-Aviv, Israel, was issued U.S. Patent No

Curis Inc., of Lexington, Mass., was issued U.S. Patent No...MiMedx Group Inc., of Kennesaw, Ga., was issued U.S. Patent No...Sequenom Inc., of San Diego, was issued U.S. Patent No

AtheroNova Inc., of Irvine, Calif., was issued U.S. Patent No...Curemark LLC, of Rye, N.Y., was issued U.S. Patent No...Dyadic International Inc., of Jupiter, Fla., was issued U.S. Patent No

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., was issued U.S. Patent No...Aeterna Zentaris Inc., of Quebec City, was issued U.S. Patent No...Ziopharm Oncology Inc., of New York, was issued U.S. Patent No

Galectin Therapeutics Inc., of Newton, Mass., was issued U.S. Patent No...GeNO LLC, of Cocoa, Fla., was issued U.S. Patent No...Trovagene Inc., of San Diego, was issued U.S. Patent No

Derma Sciences Inc., of Princeton, N.J., was issued U.S. Patent Nos...Discovery Labs Inc., of Warrington, Pa., was issued U.S. Patent No...Nuvo Research Inc., of Mississauga, Ontario, was issued U.S. Patent No

The patent also is related to treating radiation-induced mucositis, a side effect of radiation treatment for cancer...The patent is related to a method for extending the company's BH3 profiling technology, licensed from Dana Farber Cancer Institute

Athersys Inc., of Cleveland, was issued Patent No...BioLineRx Ltd., of Jerusalem, received a patent term adjustment for its patent on the composition of BCM (BL-1040), a device for prevention of cardiac remodeling following acute myocardial infarction...The patent is now extended through April 30, 2029

Aegis Therapeutics LLC, of San Diego, received U.S. Patent No...The firm also received U.S. Patent No...Amorcyte Inc., of New York, received U.S. Patent No

Resverlogix Corp., of Calgary, Alberta, received U.S. Patent No...Revotar Biopharmaceuticals AG, of Berlin, received U.S. Patent No...Virxsys Corp., of Gaithersburg, Md., received U.S. Patent No

Nutra Pharma Corp., of Coral Springs, Fla., received U.S. Patent No...Prosensa NV, of Leiden, the Netherlands, was granted U.S. Patent No

Alethia Biotherapeutics Inc., of Montreal, received U.S. Patent No...Amgen Inc., of Thousand Oaks, Calif., was issued U.S. Patent No...Asmacure Ltee, of Quebec City, received U.S. Patent No

Stem Cell Therapeutics Corp., of Calgary, Alberta, said it received U.S. Patent No...Trophos SA, of Marseille, France, was granted U.S. Patent No...Vermillion Inc., of Austin, Texas, received U.S. Patent No

Lpath Inc., of San Diego, received U.S. Patent Nos...The patent is part of the company's Trp Cage Library portfolio...Ohr Pharmaceuticals Inc., of New York, received U.S. Patent No

Acura Pharmaceuticals Inc., of Palatine, Ill., received U.S. Patent No...Advanced Cell Technology Inc., of Marlborough, Mass., received U.S. Patent No...AgonOx LLC, of Portland, Ore., received U.S. Patent No

Quest PharmaTech Inc., of Edmonton, Alberta, received a notice of allowance for a patent, titled "Combination Therapy for Treating Disease...Silence Therapeutics plc, of London, received a notice of allowance for a patent directed to the technology involved in AtuPLEX, one of its small interfering RNA delivery systems...Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Biomarkers for Peripheral Artery Disease

Alethia Biotherapeutics Inc., of Montreal, received U.S. Patent No...Convergen LifeSciences, of Austin, Texas, was granted U.S. Patent No...EffRx Pharmaceuticals SA, of Lausanne, Switzerland, received U.S. Patent No